BioCentury | Feb 10, 2014
Company News

Eboo Pharmaceuticals, FPRT Bio, MentiNova, Michael J. Fox Foundation For Parkinson's Research neurology news

...The foundation named Eboo, FPRT and MentiNova as the 2H13 participants in The Michael J. Fox...
...close in May. FPRT has rights to the product from Xencor Inc. (NASDAQ:XNCR, Monrovia, Calif.). MentiNova...
...disorders. The injectable compound, which is co-administered with levodopa, was originally developed to manage pain. MentiNova...
BioCentury | Feb 4, 2013
Financial News

MentiNova completes venture financing

MentiNova Inc. , New Brunswick, N.J. Business: Neurology Date completed: 1/25/13 Type: Venture financing Raised: Not disclosed Investor: Foundation Venture Capital Group Note: The company received an undisclosed amount of a $500,000 seed financing. WIR Staff...
Items per page:
1 - 2 of 2
BioCentury | Feb 10, 2014
Company News

Eboo Pharmaceuticals, FPRT Bio, MentiNova, Michael J. Fox Foundation For Parkinson's Research neurology news

...The foundation named Eboo, FPRT and MentiNova as the 2H13 participants in The Michael J. Fox...
...close in May. FPRT has rights to the product from Xencor Inc. (NASDAQ:XNCR, Monrovia, Calif.). MentiNova...
...disorders. The injectable compound, which is co-administered with levodopa, was originally developed to manage pain. MentiNova...
BioCentury | Feb 4, 2013
Financial News

MentiNova completes venture financing

MentiNova Inc. , New Brunswick, N.J. Business: Neurology Date completed: 1/25/13 Type: Venture financing Raised: Not disclosed Investor: Foundation Venture Capital Group Note: The company received an undisclosed amount of a $500,000 seed financing. WIR Staff...
Items per page:
1 - 2 of 2